TFX
TELEFLEX INC
NYSE · Healthcare · Medical - Instruments & Supplies · US
$141.39
+1.73%Year over year
Reported trailing growth
- Revenue
- -14.5%
- EBITDA
- —
- EBIT
- -72.8%
- EPS
- —
- Free cash flow
- -1.5%
- Operating cash flow
- -21.7%
Forward estimates
Based on analyst estimates
- Revenue
- -10.1%
- EBITDA
- +690.1%
- EPS
- +143.6%
Three-year CAGR
- Revenue
- -10.6%
- EBITDA
- -25.5%
- EBIT
- -20.0%
- Net income
- —
- EPS
- —
- Free cash flow
- -2.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026